Gara Jalqabaatti › Saree (Gosoota Hunda) › Ohio › Cincinnati
Qorannoo klinikaalii Saree (Gosoota Hunda) Cincinnati, OH keessatti
Qorannoo 27 Saree (Gosoota Hunda) f Cincinnati fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Namoota walitti qabaa jiraSadarkaa 2
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · Miili 15 fagaatti
Registry Study for Radiation Therapy Outcomes
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Cincinnati Medical Center, Cincinnati
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · Miili 8 fagaatti
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
Namoota walitti qabaa jira
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield · Miili 15 fagaatti
Pan Tumor Rollover Study
Namoota walitti qabaa jiraSadarkaa 2
- Oncology Hematology Care, Cincinnati
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Cincinnati Medical Center, Cincinnati
- West Chester Hospital, West Chester · Miili 15 fagaatti
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Namoota walitti qabaa jiraSadarkaa 2/3
- Oncology Hematology Care, Inc., Cincinnati
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Edgewood · Miili 8 fagaatti
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- USO - Oncology Hematology Care, Cincinnati
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Cincinnati, Cincinnati
Project: Every Child for Younger Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cincinnati Children's Hospital Medical Center, Cincinnati
International Rare Brain Tumor Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cincinnati Children's Hospital Medical Center, Cincinnati
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- fi 1 dabalataa
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Namoota walitti qabaa jiraSadarkaa 1/2
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Namoota walitti qabaa jiraQorannoo ilaalaa
- TriHealth Cancer Institute, Cincinnati
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Cincinnati, Cincinnati
Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
Namoota walitti qabaa jiraSadarkaa 2
- University of Cincinnati Medical Center, Cincinnati
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- TriHealth Cancer Institute, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Cincinnati
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Namoota walitti qabaa jiraSadarkaa 1
- The Christ Hospital Cancer Center, Cincinnati
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Cincinnati Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Namoota walitti qabaa jiraQorannoo ilaalaa
- TriHealth Cancer Institute, Cincinnati
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Namoota walitti qabaa jira
- University of Cincinnati, Cincinnati
- West Chester Hospital (OH394), West Chester · Miili 15 fagaatti
Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti
- Houston, TXQorannoo 121
- New York City, NYQorannoo 109
- Boston, MAQorannoo 85
- Los Angeles, CAQorannoo 74
- Nashville, TNQorannoo 65
- Philadelphia, PAQorannoo 59
- Washington, DCQorannoo 58
- Durham, NCQorannoo 58
- Chicago, ILQorannoo 51
- Atlanta, GAQorannoo 49
- Seattle, WAQorannoo 49
- Arlington, VAQorannoo 48
Qorannoo biroo Cincinnati keessatti
- Kansara Qara'a Non-Small CellQorannoo 35
- Saree OljooQorannoo 25
- Cufama OnneeQorannoo 24
- Kansarii ColorectalQorannoo 21
- Kansara MetastatikiiQorannoo 21
- Leukemia Myeloidii HamaaQorannoo 20
- Kansarii OvariiQorannoo 19
- ObesityQorannoo 19
- Dhibee QaraQorannoo 19
- Kansarii ProstateQorannoo 18
- MelanomaQorannoo 17
- Myeloma Baay’eeQorannoo 17
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.